Vistagen Therapeutics, Inc. (VTGN)
4.39
+0.14
(+3.29%)
USD |
NASDAQ |
Dec 15, 16:00
4.42
+0.03
(+0.68%)
After-Hours: 05:18
Vistagen Therapeutics Research and Development Expense (Quarterly): 15.86M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 22.56M |
| XOMA Royalty Corp. | 0.069M |
| Omeros Corp. | 15.76M |
| GeoVax Labs, Inc. | 5.044M |
| Daré Bioscience, Inc. | 0.6933M |